Patient Note — 137062
progress_notes_137062_1_deid.txt
Demographics & Encounter
Patient ID137062 (PHI redacted)
Age / Gender— / —
Date of Service2026-03-10
Provider[PROVIDER_NAME]
FacilityPOTOMAC UROLOGY CENTER - Woodbridge
PayerMedicare VA
Reason1. ELEVATED PSA
Diagnoses
N40.1
Benign prostatic hyperplasia with lower urinary tract symptoms, symptom details unspecified
R97.20
Elevated prostate specific antigen (PSA)
C61
Malignant neoplasm of prostate
C68.9
Urothelial carcinoma
Medications
Rosuvastatin Calcium
Ammonium Lactate
Clinical Summary (HPI)
Prostate Cancer (localized): [AGE]M patient with a history of Gleason 3+3=6 prostate cancer (on AS), bladder cancer s/p TURBT [Nov 2024], BPH with LUTS, and elevated PSA, presents here today for a follow up with elevated PSA. The patient reports no new complaints today. He is currently not on any medications for BPH with LUTS. *********************************** Patient denies bothersome urinary symptoms at this time. ******************************* He is voiding better after his TURBT. His path showed high grade noninvasive urothelial carcinoma. - - - - - - - - - - - - - - The patient's previous work-up history is listed below: PSA: 12.2 (January 2026) Cytology with FISH (October 2025): Negative for malignancy. Cytology with FISH (September 2025): Atypia. Prostate Biopsy Path (March 2025): Benign Prostate MRI (2/17/21): Moderate BPH with overall size measured at 65 g. He had a prior consultation to discuss PAE, but has additional questions prior to proceeding. Elevated PSA/Screening: Prostate biopsy Hx Previous biopsy? Yes Most recent biopsy result negative
Raw Note (de-identified preview)
4/15/26, 5:15 AM Print Preview
[PATIENT_NAME] DOB: [DOB] ([AGE] yo M) Acc No. [ACCOUNT_ID] DOS: 03/10/2026
[PATIENT_NAME]
[AGE] Y old Male, DOB: [DOB]
Account: [ACCOUNT_ID]: [PHONE] [ADDRESS]
Home: [PHONE]
Guarantor: [GUARANTOR_NAME] Insurance: Medicare VA
(Palmetto)
PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME]
Appointment Facility: POTOMAC UROLOGY CENTER - Woodbridge
03/10/2026 Progress Notes: [PROVIDER_NAME], MD
Reason for Appointment
1. ELEVATED PSA
History of Present Illness
Prostate Cancer (localized):
[AGE]M patient with a history of Gleason 3+3=6 prostate cancer (on AS), bladder cancer s/p TURBT [Nov 2024], BPH with
LUTS, and elevated PSA, presents here today for a follow up with elevated PSA.
The patient reports no new complaints today. He is currently not on any medications for BPH with LUTS.
***********************************
Patient denies bothersome urinary symptoms at this time.
*******************************
He is voiding better after his TURBT. His path showed high grade noninvasive urothelial carcinoma.
- - - - - - - - - - - - - -
The patient's previous work-up history is listed below:
PSA: 12.2 (January 2026)
Cytology with FISH (October 2025): Negative for malignancy.
Cytology with FISH (September 2025): Atypia.
Prostate Biopsy Path (March 2025): Benign
Prostate MRI (2/17/21): Moderate BPH with overall size measured at 65 g. He had a prior consultation to discuss PAE, but
has additional questions prior to proceeding.
Elevated PSA/Screening:
Prostate biopsy Hx
Previous biopsy? Yes
Most recent biopsy result negative
Current Medications
Not-Taking
Rosuvastatin Calcium 20 MG Tablet TAKE 1 TABLET BY MOUTH EVERY DAY IN THE EVENING Oral
Ammonium Lactate 12 % Lotion External
Past Medical History
Memory issues.
Surgical History
shoulder surgery
prostate biopsy
PAE
Family History
Progress Note: [PROVIDER_NAME], MD 03/10/2026
Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
Generated for Printing/Faxing/eTransmitting on: 04/15/2026 08:15 AM EDT
1/3
4/15/26, 5:15 AM Print Preview
[PATIENT_NAME] DOB: [DOB] ([AGE] yo M) Acc No. [ACCOUNT_ID] DOS: 03/10/2026
Father: deceased, alzheimer's dementia
Mother: deceased
Social History
Recreational drug use: no.
Exercise: yes.
Caffeine: yes, frequency:.
Sexually active: yes.
Occupation: no, Retired.
Screening
Allergies
N.K.D.A.
Hospitalization/Major Diagnostic Procedure
Denies Past Hospitalization
Review of Systems
11 system Review of Systems completed in the chart and all pertinent positives and negatives reviewed with the
patient, afg.
Vital Signs
Assessments
1.Benign prostatic hyperplasia with lower urinary tract symptoms, symptom details unspecified - N40.1 (Primary)
2.Elevated prostate specific antigen (PSA) - R97.20
3.Malignant neoplasm of prostate - C61
4.Urothelial carcinoma - C68.9
Treatment
1.Benign prostatic hyperplasia with lower urinary tract symptoms, symptom details unspecified
Notes: [AGE]M patient with a history of Gleason 3+3=6 prostate cancer (on AS), bl